Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery

Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery

Background: Prostate-specific membrane antigen (PSMA) targeted molecular imaging using positron emission tomography (PET) has significantly improved the diagnosis and treatment of prostate cancer (PCA). Objective: To assess the feasibility and compare the diagnostic accuracy of [68Ga]Ga-PSMA-11 PET...

Full description

Bibliographic Details
Main Authors: Nicolai Huebner, Sazan Rasul, Pascal Baltzer, Paola Clauser, Karl Hermann Grubmüller, Markus Mitterhauser, Marcus Hacker, Axel Heidenreich, Pawel Rajwa, Harun Fajkovic, Shahrokh F. Shariat, Bernhard Grubmüller
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:European Urology Open Science
Subjects:
Prostate-specific membrane antigen
Prostate cancer
Cytoreductive surgery
Radical prostatectomy
Hormone therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168322000787

Internet

http://www.sciencedirect.com/science/article/pii/S2666168322000787

Similar Items